Locally Advanced or Metastatic and Unresectable HCC
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic and Unresectable HCC
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC (NCT03764293) | Jiangsu HengRui Medicine Co., Ltd. | 2019-06-10 |
Track Locally Advanced or Metastatic and Unresectable HCC automatically
Every clearance here is in the API, with alerts when new ones post.